Pharmacokinetic and pharmacodynamic drug interactions with polypharmacotherapy of treatment-resistant affective and obsessive-compulsive disorders

Psychopharmacology Bulletin

Volumn 32, Issue 4, 1996, Pages 555-568

  Carson, Stanley W ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Affective disorders; Drug interactions; Pharmacodynamics; Pharmacokinetics; Polytherapy

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CYTOCHROME P450; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

AFFECTIVE NEUROSIS; ALGORITHM; CONFERENCE PAPER; DRUG INHIBITION; DRUG METABOLISM; DRUG POTENTIATION; HUMAN; OBSESSION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL;

ANTIDEPRESSIVE AGENTS; DRUG INTERACTIONS; HUMANS; MOOD DISORDERS; OBSESSIVE-COMPULSIVE DISORDER;

EID: 0030454637     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Baetz, M, and Malcolm, D. Serotonin syndrome from fluvoxamine and buspirone (letter). Can. J. Psychiatry 40(7):428-429, 1995.